Predictive Modeling of Hypoglycemia Risk with Basal Insulin Use in Type 2 Diabetes: Use of Machine Learning in the LIGHTNING Study

von Bosnyak, Zsolt, Zhou, Fang Liz, Jimenez, Javier, Berria, Rachele
Veröffentlicht in Diabetes Ther (2019)

Hypoglycaemia risk with insulin glargine 300 U/mL compared with glargine 100 U/mL across different baseline fasting C‐peptide levels in insulin‐naïve people with type 2 diabetes: A...

von Bolli, Geremia B., Landgraf, Wolfgang, Bosnyak, Zsolt, Melas‐Melt, Lydie, Home, Philip D.
Veröffentlicht in Diabetes Obes Metab (2020)

Maternal Glycemia and Risk of Large-for-Gestational-Age Babies in a Population-Based Screening

von Kerényi, Zsuzsa, Tamás, Gyula, Kivimäki, Mika, Péterfalvi, Andrea, Madarász, Eszter, Bosnyák, Zsolt, Tabák, Adam G.
Veröffentlicht 2009

InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring—Stu...

von Battelino, Tadej, Bosnyak, Zsolt, Danne, Thomas, Mukherjee, Bhaswati, Edelman, Steve, Pilorget, Valerie, Choudhary, Pratik, Renard, Eric, Bergenstal, Richard
Veröffentlicht in Diabetes Ther (2020)

Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose...

von Battelino, Tadej, Bosnyak, Zsolt, Danne, Thomas, Mukherjee, Bhaswati, Edelman, Steve, Pilorget, Valerie, Choudhary, Pratik, Renard, Eric, Bergenstal, Richard
Veröffentlicht in Diabetes Ther (2020)

Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose...

von Battelino, Tadej, Bosnyak, Zsolt, Danne, Thomas, Mukherjee, Bhaswati, Edelman, Steve, Pilorget, Valerie, Choudhary, Pratik, Renard, Eric, Bergenstal, Richard
Veröffentlicht in Diabetes Ther (2020)

Glycaemic control and hypoglycaemia risk with insulin glargine 300 U/mL and insulin degludec 100 U/mL in older participants in the BRIGHT trial

von Bolli, Geremia B., Cheng, Alice, Charbonnel, Bernard, Aroda, Vanita R., Westerbacka, Jukka, Bosnyak, Zsolt, Boëlle‐Le Corfec, Emmanuelle, Rosenstock, Julio
Veröffentlicht in Diabetes Obes Metab (2021)

Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300...

von Sullivan, Sean D., Bailey, Timothy S., Roussel, Ronan, Zhou, Fang Liz, Bosnyak, Zsolt, Preblick, Ronald, Westerbacka, Jukka, Gupta, Rishab A., Blonde, Lawrence
Veröffentlicht in Diabetes Obes Metab (2018)

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING St...

von Pettus, Jeremy, Roussel, Ronan, Liz Zhou, Fang, Bosnyak, Zsolt, Westerbacka, Jukka, Berria, Rachele, Jimenez, Javier, Eliasson, Björn, Hramiak, Irene, Bailey, Timothy, Meneghini, Luigi
Veröffentlicht in Diabetes Ther (2019)

Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D real‐world stu...

von Sullivan, Sean D., Nicholls, Charlie J., Gupta, Rishab A., Menon, Arjun A., Wu, Jasmanda, Westerbacka, Jukka, Bosnyak, Zsolt, Frias, Juan P., Bailey, Timothy S.
Veröffentlicht in Diabetes Obes Metab (2019)

Similar glycaemic control and less hypoglycaemia during active titration after insulin initiation with glargine 300 units/mL and degludec 100 units/mL: A subanalysis of the BRIGHT...

von Cheng, Alice, Harris, Stewart, Giorgino, Francesco, Seufert, Jochen, Ritzel, Robert, Khunti, Kamlesh, Lauand, Felipe, Melas‐Melt, Lydie, Westerbacka, Jukka, Bosnyak, Zsolt, Rosenstock, Julio
Veröffentlicht in Diabetes Obes Metab (2019)

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial

von Haluzík, Martin, Cheng, Alice, Müller‐Wieland, Dirk, Westerbacka, Jukka, Bosnyak, Zsolt, Lauand, Felipe, Melas‐Melt, Lydie, Karalliedde, Janaka, Rosenstock, Julio, Bolli, Geremia B.
Veröffentlicht in Diabetes Obes Metab (2020)